Sign in
4/A

Changes in Ownership

Akebia Therapeutics, Inc. Filed Acc 0001209191-15-058358

SVP, General Counsel, Sec. sold 1,483 shares at $9.09 ($13,478)

From the SEC's structured data for this filing

Trades in this filing

Hadas Nicole R. · SVP, General Counsel, Sec.

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2015-04-02 Sale : show line 1 in the form −1,483 $9.09 $13,478 67,015 D
Open-market sales · 1,483 sh · avg $9.09 · $13,478
Loading xslF345X03/doc4a.xml…